SA
Sicart Associates Portfolio holdings
AUM
$286M
This Quarter Return
+5.64%
1 Year Return
+26.32%
3 Year Return
+72.95%
5 Year Return
+137.71%
10 Year Return
–
AUM
$138M
AUM Growth
+$138M
(-4.5%)
Cap. Flow
-$12.3M
Cap. Flow
% of AUM
-8.91%
Top 10 Holdings %
Top 10 Hldgs %
47.06%
Holding
111
New
11
Increased
36
Reduced
31
Closed
24
Top Buys
| 1 |
Patterson-UTI
PTEN
|
$7M |
| 2 |
Intel
INTC
|
$3.71M |
| 3 |
Ionis Pharmaceuticals
IONS
|
$3.5M |
| 4 |
iShares MSCI France ETF
EWQ
|
$1.82M |
| 5 |
iShares MSCI United Kingdom ETF
EWU
|
$1.74M |
Top Sells
| 1 |
PTC Therapeutics
PTCT
|
$4.7M |
| 2 |
UTEK
Ultratech Inc.
UTEK
|
$4.61M |
| 3 |
Johnson Controls International
JCI
|
$2.15M |
| 4 |
Marathon Petroleum
MPC
|
$2.12M |
| 5 |
AGN
Allergan plc
AGN
|
$2.09M |
Sector Composition
| 1 | Technology | 22.62% |
| 2 | Energy | 20.47% |
| 3 | Healthcare | 19.39% |
| 4 | Materials | 5.38% |
| 5 | Communication Services | 5.2% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
101
Marathon Petroleum
MPC
$54.4B
| – | – |
-42,000
| Closed | -$2.12M |
|
102
M&T Bank
MTB
$31B
| – | – |
-3,000
| Closed | -$469K |
|
103
Pitney Bowes
PBI
$2.07B
| – | – |
-15,000
| Closed | -$228K |
|
|
104
PTC Therapeutics
PTCT
$4.41B
| – | – |
-431,135
| Closed | -$4.7M |
|
105
ProShares UltraShort QQQ
QID
$279M
| – | – |
-125
| Closed | -$239K |
|
106
Sangamo Therapeutics
SGMO
$161M
| – | – |
-101,950
| Closed | -$311K |
|
107
Target
TGT
$42B
| – | – |
-6,150
| Closed | -$444K |
|
108
Williams-Sonoma
WSM
$23.4B
| – | – |
-14,580
| Closed | -$353K |
|
109
Xerox
XRX
$478M
| – | – |
-19,544
| Closed | -$450K |
|
|
GST
110
DELISTED
Gastar Exploration Inc.
GST
| – | – |
-23,000
| Closed | -$36K |
|
|
UTEK
111
DELISTED
Ultratech Inc.
UTEK
| – | – |
-192,035
| Closed | -$4.61M |
|